birdflustocks.com
Home
Facts
Idea
Stocks
Brokers
admin
birdflustocks.com
»
admin
admin
CureVac/BioNTech: BioNTech will acquire CureVac in an all share deal with a 55% premium
By
admin
|
12
Jun, 25
|
Moderna: BARDA funding for phase 3 H5N1 vaccine trial terminated
By
admin
|
28
May, 25
|
Moderna: Positive phase 1/2 H5N1 vaccine interim data
By
admin
|
28
May, 25
|
CureVac/BioNTech: European Patent Office maintains amended CureVac patent EP 3 708 668 B1 challenged by BioNTech
By
admin
|
27
Mar, 25
|
This is not the critical litigation regarding patent EP 1
GSK: Canada orders 500.000 H5N1 vaccine doses
By
admin
|
19
Feb, 25
|
PHAC will provide vaccines to provinces and territories based on
Moderna: 590 million USD BARDA funding for bird flu mRNA vaccine development
By
admin
|
17
Jan, 25
|
The U.S. Department of Health and Human Services (HHS) will
Arcturus Therapeutics: Phase 1 H5N1 mRNA vaccine trial initiated
By
admin
|
10
Jan, 25
|
"Interim Phase 1 data expected H2 2025 (...) Arcturus Therapeutics
CSL: United Kingdom government orders 5 million H5 vaccine doses
By
admin
|
3
Dec, 24
|
The UK Government has agreed a contract for more than
Cidara Therapeutics: 105 million USD private placement funding announced
By
admin
|
21
Nov, 24
|
Pursuant to the terms of the securities purchase agreement, Cidara
Arcturus Therapeutics: FDA clearance for Arcturus Therapeutics phase 1 bird flu vaccine trial
By
admin
|
11
Nov, 24
|
Arcturus Therapeutics (..._ today announced that the U.S. Food and
1
2
3
…
5
Next